查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1991559

全球切片檢查市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Cancer Biopsy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計切片檢查市場將從 2025 年的 424 億美元成長到 2034 年的 1,173 億美元，2026 年至 2034 年的複合年成長率為 11.97%。

由於癌症發生率不斷上升以及早期診斷的重要性日益凸顯，全球癌症切片檢查市場正經歷顯著成長。切片檢查是確診癌症和製定合適治療方案的關鍵步驟。隨著癌症篩檢意識的提高和微創診斷技術的廣泛應用，醫療專業人員越來越依賴先進的切片檢查技術來提高診斷準確性和改善患者預後。

推動該市場成長的因素包括診斷影像技術的進步、液態生物檢體技術的發展以及腫瘤學研究投入的增加。液態生物檢體尤其引人注目，因為它可以透過血液樣本檢測癌症生物標記物，從而減少侵入性手術的需求。此外，精準醫療和個人化癌症治療方法的日益普及也推動了對可靠切片檢查診斷的需求。

隨著技術創新不斷革新癌症診斷，癌症切片檢查市場前景看好。新的診斷技術、人工智慧在病理學中的應用以及生物標記檢測方法的改進，有望提升診斷能力。在醫療成本不斷上漲和政府大力推動癌症早期篩檢計畫的推動下，預計未來幾年該市場將迎來顯著成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球癌症切片檢查市場：按產品分類

  • 市場分析、洞察與預測
  • 平台和設備
  • 試劑盒和試劑
  • 服務

第5章 全球癌症切片檢查市場：按類型分類

  • 市場分析、洞察與預測
  • 組織切片檢查
  • 液態生物檢體
  • 其他

第6章：全球癌症切片檢查市場：按應用領域分類

  • 市場分析、洞察與預測
  • 乳癌
  • 結腸癌
  • 子宮頸癌
  • 肺癌
  • 攝護腺癌
  • 皮膚癌
  • 血癌
  • 腎癌
  • 肝癌
  • 胰臟癌
  • 卵巢癌
  • 其他

第7章 全球癌症切片檢查市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Becton
    • Dickinson And Company
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • Agilent Technologies Inc
    • Lllumina Inc
    • Siemens Healthineers
    • GE Healthcare
    • Bio-Rad Laboratories Inc
    • Olympus Corporation
    • Qiagen
簡介目錄
Product Code: VMR11213945

The Cancer Biopsy Market size is expected to reach USD 117.30 Billion in 2034 from USD 42.40 Billion (2025) growing at a CAGR of 11.97% during 2026-2034.

The global cancer biopsy market is witnessing substantial growth due to the increasing prevalence of cancer and the rising importance of early disease diagnosis. Biopsy procedures are essential for confirming cancer diagnoses and determining appropriate treatment strategies. With growing awareness about cancer screening and the rising adoption of minimally invasive diagnostic procedures, healthcare providers are increasingly relying on advanced biopsy techniques to improve diagnostic accuracy and patient outcomes.

Several factors are driving the growth of this market, including advancements in imaging technologies, the development of liquid biopsy techniques, and increasing investments in oncology research. Liquid biopsy, in particular, has gained attention as it allows the detection of cancer biomarkers through blood samples, reducing the need for invasive procedures. Additionally, the growing adoption of precision medicine and personalized cancer treatment approaches is increasing the demand for reliable biopsy diagnostics.

The future of the cancer biopsy market looks promising as technological innovations continue to transform cancer diagnostics. Emerging diagnostic technologies, integration of artificial intelligence in pathology, and improved biomarker detection methods are expected to enhance diagnostic capabilities. With increasing healthcare expenditure and government initiatives promoting early cancer detection programs, the market is expected to experience significant growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Platforms & Instruments
  • Kits & Reagents
  • Services

By Type

  • Tissue Biopsies
  • Liquid Biopsies
  • Others

By Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Skin Cancer
  • Blood Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Others

COMPANIES PROFILED

  • Abbott Laboratories, Becton, Dickinson and Company, F HoffmannLa Roche Ltd, Hologic Inc, Danaher Corporation, Thermo Fisher Scientific Inc, Agilent Technologies Inc, lllumina Inc, Siemens Healthineers, GE Healthcare, BioRad Laboratories Inc, Olympus Corporation, Qiagen
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CANCER BIOPSY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Platforms & Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CANCER BIOPSY MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Tissue Biopsies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Liquid Biopsies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CANCER BIOPSY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cervical Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Skin Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.8. Blood Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.9. Kidney Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.10. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.11. Pancreatic Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.12. Ovarian Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.13. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CANCER BIOPSY MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Type
    • 7.2.3 By Application
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Type
    • 7.3.3 By Application
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Type
    • 7.4.3 By Application
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Type
    • 7.5.3 By Application
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Type
    • 7.6.3 By Application
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CANCER BIOPSY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Becton
    • 9.2.3 Dickinson And Company
    • 9.2.4 F. Hoffmann-La Roche Ltd
    • 9.2.5 Hologic Inc
    • 9.2.6 Danaher Corporation
    • 9.2.7 Thermo Fisher Scientific Inc
    • 9.2.8 Agilent Technologies Inc
    • 9.2.9 Lllumina Inc
    • 9.2.10 Siemens Healthineers
    • 9.2.11 GE Healthcare
    • 9.2.12 Bio-Rad Laboratories Inc
    • 9.2.13 Olympus Corporation
    • 9.2.14 Qiagen